DCC is a sales, marketing, distribution and business support services Group, operating across five divisions. DCC Energy, DCC SerCom (IT and entertainment products), DCC Healthcare, DCC Environmental and DCC Food and Beverage.
In the medical area, the business markets and sells a broad range of products in areas such as woundcare, urology, procedure packs, critical care (anaesthesia, endovascular, cardiology, IV access) and diagnostics. Products are typically single use/consumable in nature. DCC represents leading medical, surgical and scientific brands including BioRad, Boston Scientific, Diagnostica Stago, ICU Medical, Molnlycke, Oxoid, Smiths Medical and Zeiss through its extensive field sales force of highly trained professionals. In Britain, DCC is also seeking to build a growth platform in the provision of stock management and distribution services to hospitals and healthcare brand owners/manufacturers as british acute care hospitals look for customised just-in-time distribution solutions to deliver cost savings and improve product availability. In the pharma area, DCC Healthcare is involved in the sales, marketing and distribution of pharmaceuticals, primarily IV pharmaceuticals for the hospital sector in areas such as oncology, haematology, neurology and anaesthesia. DCC works with leading brands like Fresenius Kabi, Grifols, Martindale Pharma and Sandoz, as well as generic companies.The business is increasingly focussed on developing its range of pharma services including value added logistics in Britain and its growing business in the provision of IV compounding services to hospitals in Ireland. DCC has significantly expanded the capacity of its licensed compounding facility, which is involved in the aseptic filling of oncology, pain management, antibiotic and paediatric nutrition products into patient ready dosage forms, i.e. syringes or IV bags, and is leveraging this capacity to expand its service offering, including into the provision of pharma homecare services in Ireland.
DCC Healthcare is continually expanding its product portfolio in both the medical and pharma sectors organically and through bolt on acquisition. In the pharma sector, in addition to growing its compounding service business, DCC Healthcare is seeking to expand in other service areas and to further develop its pharma sales and marketing activities into new product formats and channels to market.
DCC Health & Beauty Solutions – DCC Health & Beauty Solutions is a leading provider of “source to shelf” outsourced solutions to the health and beauty industry, principally in the areas of nutraceuticals (vitamin and health supplements), skin care and hair care. Customers include leading premium brand owners, mail order companies, specialist health and beauty retailers and private label suppliers in Britain, continental Europe and other markets. DCC provides a wide range of product formats (tablets, soft gel and hard shell capsules, creams and liquids), packing and other services from its three MHRA licensed facilities in Britain. The quality of these facilities, together with the strength and depth of DCC’s business development and technical resources, enables DCC to assist its customers in rapidly bringing new products from marketing concept through to finished, shelf-ready products. DCC’s key strength is the highly responsive and flexible service it provides to its customers. This service typically involves product development, formulation, stability and other testing and regulatory compliance, as well as manufacturing and packing.